Session sponsor
4.45pm – 5.15pm BST, 25 September 2023 ‐ 30 mins
Room: Hall 7
Tissue Recognition Programme
Consultant Biomedical Scientist in Cytology, Royal Devon & Exeter NHS Foundation Trust
Scheme Manager , UK NEQAS ICC & ISH
Suzanne has been the Scheme Manager for the UK NEQAS Immunocytochemistry and In Situ Hybridisation Scheme since 2018. Her principal role is to oversee all operational aspects of the large international organisation, monitoring quality within the setting of clinical healthcare services. She started her career as a Biomedical Scientist in Cellular Pathology in 1994 after graduating with a Biomedical Sciences degree.
Suzanne went on to complete her professional training in Cellular pathology, and successfully obtained state registration to the HCPC, and then her MSc in Biomedical Sciences, and Fellow membership within the IBMS. Her previous work appointments have primarily been within the field of cellular pathology, in both the clinical diagnostic and research fields.
Suzanne has a keen interest in education and is a module tutor for the MSc Biomed Online Course at the University of Greenwich. She is also a member of the Institute of Biomedical Sciences Cellular Pathology Advisory Committee.
Consultant Biomedical Scientist in Cytology, Royal Devon & Exeter NHS Foundation Trust
Tracey has now been an employee of the NHS as a Cytologist for the last 35 years and she remains passionate about the subject. She is originally from Lanarkshire in Scotland but began her cytology career in London. Tracey currently works in the Cytology department at the Royal Devon and Exeter Hospital in Devon.
Tracey is a consultant biomedical scientist and laboratory manager. She is also the training co-ordinator for Cellular Pathology and a Quality manager. Since the transfer of the cervical cytology service to Bristol she no longer reports these cases; however she continues to report diagnostic cytology and attend ENT, thyroid, EUS Pancreas and EBUS clinics as part of our ROSE setup.
Tracey is a member of the IBMS Cytopathology Advisory Panel and was involved in the work to create the new diagnostic cytology specialist portfolio.